Document is current
Any future updates will be listed below
-
Authors
Leisser, Christoph
Findl, Oliver
- License Information
-
More Information
Article History
Received: 1 April 2022
Accepted: 12 July 2022
First Online: 15 August 2022
Declarations
:
: C. Leisser and O. Findl declare that they have no competing interests. O. Findl is a scientific advisor for Alcon, Croma, Carl Zeiss Meditec AG, Johnson & Johnson and Merck, but has no personal interest in the products mentioned.
: All research and measurements followed the tenets of The Declaration of Helsinki and were approved by the local ethics committee of the city of Vienna (EK 20-167-VK). Clinical trials registration: NCT 04883697.
